Why the study?
Neuropathic pain and cognitive dysfunction are increasingly recognized in familial chylomicronaemia syndrome, prompting detailed quantification of somatic and autonomic neuropathy in this population.
Is familial chylomicronemia syndrome associated with somatic and autonomic neuropathy compared to healthy controls?
Is familial chylomicronemia syndrome associated with somatic and autonomic neuropathy compared to healthy controls?
Familial chylomicronemia syndrome is associated with significant somatic and autonomic neuropathy, including small nerve fiber damage and cardiac autonomic dysfunction, independent of glycemic status.
May warrant neuropathy screening in FCS; leaves open causal links and need for prospective studies.
Background & Objectives Familial chylomicronaemia syndrome (FCS) is a rare autosomal recessive disorder associated with markedly elevated triglyceride concentration and acute pancreatitis, but neuropathic pain and cognitive dysfunction are also increasingly recognised. This study undertook detailed quantification of somatic and autonomic neuropathy in participants with FCS. Methods Sixteen individuals with FCS and sixteen age and sex-matched controls underwent assessment of the lipid profile, neuropathic symptoms and disability, vibration perception, corneal confocal microscopy (CCM) and cardiac autonomic reflex testing. Results Age [36.4 (26.5 – 47.2) vs. 36.7 (31.3 – 46.9) years, p = 0.7], gender distribution [males 44% (n=7) vs. 50% (n=8), p = 0.7], body mass index (BMI) (23.7 [20.3-27.1] vs. 24.7 [22.3-27.2] kg/m 2 , p = 0.5), and HbA1c (36.0 [32.5 – 39.2] vs. 36.8 [33.0 – 38.0] mmol/mol, p = 0.9) were comparable between participants with FCS and controls. Triglycerides were significantly higher [23.7 (17.4 – 34.8) vs. 1.0 [0.7 – 1.3) mmol/L, p <0.001), whilst LDL-C [0.9 (0.7 – 1.2) vs. 2.7 (2.3 – 3.1) mmol/L, p <0.001) and HDL-C [0.4 (0.3 – 0.6) vs 1.5 [1.3 – 1.9] mmol/L, p <0.001) were lower in participants with FCS. The Neuropathy Symptom Profile score [4 (0 – 14) vs 0, p =0.003], Neuropathy Disability Score [1 (0 – 3.5) vs 0, p = 0.01] and vibration perception threshold [6.5 (4.7 – 8.1) vs 3.0 (2.0 – 3.5) volts, p <0.001] were higher, whilst corneal nerve fibre density [30.2 (27.3 – 32.3) vs 37.0 (32.5 – 38.5) no./mm 2 , p <0.001], corneal nerve branch density [54.1 (42.0 – 76.6) vs 100.5 (67.0 – 147.1) no./mm 2 , p <0.001], corneal nerve fibre length [20.0 (18.3 – 25.5) vs 27.5 (23.9 – 34.3) mm/mm 2 , p <0.001], deep breathing heart rate variability [17.0 (14.2 – 28.0) vs 29.5 (25.2 – 34.7) beats/min, p =0.002] and E–I ratio [1.18 (1.14 – 1.29) vs 1.36 (1.25 – 1.41), p =0.001] were lower in participants with FCS compared to controls. Conclusion FCS is associated with neuropathic symptoms, elevated vibration perception, small nerve fibre damage and cardiac autonomic dysfunction.
No takes yet. Share an insight, caveat, or question.
Pasha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: